Literature DB >> 27003382

Pigment Epithelium-Derived Factor Inhibits Oxygen-Induced Retinal Neovascularization in a Murine Model.

Shulian Zhang1, Guanpeng Zhai2, Wenjing Shi1, Yuhuan Wang1, Li Zhu1, Yi Dai1, Chao Chen1.   

Abstract

BACKGROUND: The inhibitory effects of pigment epithelium-derived factor (PEDF) on retinal neovascularization were observed in a murine model of oxygen-induced retinopathy.
METHODS: PEDF was administered via intravitreal injection into the right eye of mice subjected to hyperoxia. The proliferative neovascular response was assessed by evaluating the vascular pattern in retinal flat-mounts and quantified by counting the number of new vascular cell nuclei extending into the internal limiting membrane. Retinas were stained for vascular endothelial growth factor (VEGF), PEDF, and CD31 with immunohistochemical method.
RESULTS: The effect of PEDF on retinal neovascularization is related to the postnatal age at the time of injection and the number of injections. The injection of 2 µg of PEDF at postnatal day 12 (P12) and P14 markedly inhibited retinal neovascularization.
CONCLUSION: Locally administered PEDF is a potentially effective vascular inhibitory factor for the treatment and prevention of retinopathy of prematurity.

Entities:  

Keywords:  pigment epithelium-derived factor; retinal neovascularization; retinopathy of prematurity

Mesh:

Substances:

Year:  2016        PMID: 27003382     DOI: 10.3109/15513815.2016.1147626

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  3 in total

1.  Effects of microRNA-29a on retinopathy of prematurity by targeting AGT in a mouse model.

Authors:  Xin-Ke Chen; Li-Juan Ouyang; Zheng-Qin Yin; Yuan-You Xia; Xiu-Rong Chen; Hui Shi; Yan Xiong; Lian-Hong Pi
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

2.  Serum pigment epithelium-derived factor: Relationships with cardiovascular events, renal dysfunction, and mortality in the Veterans Affairs Diabetes Trial (VADT) cohort.

Authors:  Kelly J Hunt; Alicia J Jenkins; Dongxu Fu; Danielle Stevens; Jian-Xing Ma; Richard L Klein; Madona Azar; Sarah X Zhang; Maria F Lopes-Virella; Timothy J Lyons
Journal:  J Diabetes Complications       Date:  2019-07-26       Impact factor: 2.852

3.  Identification of proteins associated with paclitaxel resistance of epithelial ovarian cancer using iTRAQ-based proteomics.

Authors:  Yuanjing Wang; Hongxia Li
Journal:  Oncol Lett       Date:  2018-04-27       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.